| URL | https://www.businesswire.com/news/home/20230919863 |
| Source | business wire |
| Date Published | 09/19/2023 |
| Company/Division name | Rising Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2023 |
| Domestically, the work will be done: | In-house |
| City reshored to: | East Brunswick |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma/ injectables and ophthalmic products |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption |